barts-ms case study 1 - part 2 18 jan 2016
Published Streamed 8 years ago • 325 plays • Length 8:06Download video MP4
Download video MP3
Similar videos
-
11:49
barts-ms neurospeak case study 1: 13h00 18-jan-16
-
52:51
barts-ms journal club ide smets on ris - 2
-
10:42
barts-ms coronavirus antibody study
-
58:51
treating ms in 2014 - professor gavin giovannoni
-
46:05
barts-ms hangout - january 2019
-
10:18
other environmental factors part 2 - prof gavin giovannoni
-
![dr. boster offers his opinion regarding alemtuzumab in multiple sclerosis [part 2]](https://i.ytimg.com/vi/6GBnKk3s3cE/mqdefault.jpg)
6:09
dr. boster offers his opinion regarding alemtuzumab in multiple sclerosis [part 2]
-
22:35
barts-ms research day 2015 - introduction talks
-
22:35
barts-ms research day 2015 - basic talk
-
23:57
stornoway healthcare professionals day: diagnosing ms by gavin giovannoni
-
43:44
barts ms journal club 26 jan 2021 ide smets ofatumumab vs teriflunomide
-
56:03
ms variance '19 – lifelong brain health as a target for ms service provision (prof gavin giovannoni)
-
44:13
ms academy webinar - early-effective treatment: case study discussion
-
1:51
the benefits of treatments with minimal scientific basis in ms
-
5:17
1/10 what is multiple sclerosis? | professor gavin giovannoni
-
8:03
10/30/2018 - session 2: bart
-
0:59
gavin giovannoni: the importance of treating multiple sclerosis early and effectively
-
1:50
lessons to be learned from the laquinimod trial for ms
-
2:04
future avenues of ms treatment